NO824420L - Fremgangsmaate til fremstilling av n-oksydforbindelser med kardiovaskulaere egenskaper, spesielt antihypertensiv virkning - Google Patents

Fremgangsmaate til fremstilling av n-oksydforbindelser med kardiovaskulaere egenskaper, spesielt antihypertensiv virkning

Info

Publication number
NO824420L
NO824420L NO824420A NO824420A NO824420L NO 824420 L NO824420 L NO 824420L NO 824420 A NO824420 A NO 824420A NO 824420 A NO824420 A NO 824420A NO 824420 L NO824420 L NO 824420L
Authority
NO
Norway
Prior art keywords
formula
lower alkyl
residue
compounds
pyridine
Prior art date
Application number
NO824420A
Other languages
English (en)
Norwegian (no)
Inventor
Markus Zimmermann
Hans Kuehnis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO824420L publication Critical patent/NO824420L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO824420A 1981-12-30 1982-12-30 Fremgangsmaate til fremstilling av n-oksydforbindelser med kardiovaskulaere egenskaper, spesielt antihypertensiv virkning NO824420L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH835981 1981-12-30
CH225582 1982-04-14

Publications (1)

Publication Number Publication Date
NO824420L true NO824420L (no) 1983-07-01

Family

ID=25689928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO824420A NO824420L (no) 1981-12-30 1982-12-30 Fremgangsmaate til fremstilling av n-oksydforbindelser med kardiovaskulaere egenskaper, spesielt antihypertensiv virkning

Country Status (18)

Country Link
US (1) US4497808A (el)
EP (1) EP0083315B1 (el)
AT (1) ATE28643T1 (el)
AU (1) AU556201B2 (el)
CA (1) CA1215053A (el)
DD (1) DD209456A5 (el)
DE (1) DE3276862D1 (el)
DK (1) DK580282A (el)
ES (4) ES8405783A1 (el)
FI (1) FI824531A7 (el)
GB (1) GB2112782B (el)
GR (1) GR77073B (el)
HU (1) HU192760B (el)
IE (1) IE54496B1 (el)
IL (1) IL67602A0 (el)
NO (1) NO824420L (el)
NZ (1) NZ202959A (el)
PT (1) PT76057B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPH0676405B2 (ja) * 1986-06-13 1994-09-28 日清製粉株式会社 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
USD1044219S1 (en) * 2021-06-04 2024-10-01 Crocs, Inc. Footwear

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792765A1 (de) * 1965-11-10 1974-10-10 Bayer Ag Verwendung von dihydrodipyridylen als kreislaufbeeinflussende mittel
DE1545873A1 (de) * 1965-11-10 1970-02-26 Bayer Ag Verfahren zur Herstellung von Dihydrodipyridylderivaten
US3862161A (en) * 1970-01-24 1975-01-21 Bayer Ag 4-pyridyl substituted 1,4-dihydropyridines
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US3966948A (en) * 1970-01-24 1976-06-29 Bayer Aktiengesellschaft Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods
US3933834A (en) * 1972-03-06 1976-01-20 Bayer Aktiengesellschaft Unsymmetrical esters of N-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid
US3920823A (en) * 1972-03-06 1975-11-18 Bayer Ag Use of unsymmetrical esters of n-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid as cardio-vascular agents
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES530655A0 (es) 1985-12-01
US4497808A (en) 1985-02-05
IE823092L (en) 1983-06-30
ES518711A0 (es) 1984-06-16
DE3276862D1 (en) 1987-09-03
AU556201B2 (en) 1986-10-23
GB2112782B (en) 1985-05-01
ES530654A0 (es) 1986-11-16
IL67602A0 (en) 1983-05-15
ES8701160A1 (es) 1986-11-16
FI824531A0 (fi) 1982-12-30
DK580282A (da) 1983-07-01
GR77073B (el) 1984-09-05
ES530653A0 (es) 1985-12-16
CA1215053A (en) 1986-12-09
HU192760B (en) 1987-07-28
AU9195982A (en) 1983-07-07
PT76057A (en) 1983-01-01
ATE28643T1 (de) 1987-08-15
GB2112782A (en) 1983-07-27
NZ202959A (en) 1985-11-08
PT76057B (en) 1986-02-04
ES8405783A1 (es) 1984-06-16
ES8602666A1 (es) 1985-12-01
IE54496B1 (en) 1989-10-25
EP0083315A3 (en) 1983-08-24
EP0083315A2 (de) 1983-07-06
FI824531L (fi) 1983-07-01
ES8603456A1 (es) 1985-12-16
FI824531A7 (fi) 1983-07-01
EP0083315B1 (de) 1987-07-29
DD209456A5 (de) 1984-05-09

Similar Documents

Publication Publication Date Title
AU740318B2 (en) Dihydropyrimidines
JP4310437B2 (ja) 縮合フラン化合物
US4497808A (en) N-Oxide compounds useful in the treatment of cardiovascular ailments
JP2019532984A (ja) Ｂ型肝炎ウイルス感染症の処置及び予防のための新規なテトラヒドロピリドピリミジン
US4735956A (en) Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
EP1390371B1 (en) Oxazolo-and furopyrimidines and their use in medicaments against tumors
SK7592000A3 (en) Tricyclic compound substituted by the heterocyclic group, pharmaceutical composition containing such compound and use thereof
AU2004230952A1 (en) Beta-carbolines useful for treating inflammatory disease
CS249516B2 (en) Method of dihydropiridines production
EP1735311B1 (en) Beta-carbolines useful for treating inflammatory disease
KR20070083906A (ko) 혈관 내피 성장 인자 (ｖｅｇｆ) 수용체 키나제 억제제로서신규 안트라닐아미드 피리딘우레아
CS241549B2 (en) Method of 1,4-dihydropyridines production
EP0111453A1 (de) Amid-Verbindungen
JPS61257983A (ja) １，４−ジヒドロピリジン及びこれを有効成分とする医薬組成物
WO2000078720A1 (en) Novel dihydropyridine derivative
KR910001137B1 (ko) 티에노 피리딘 유도체 및 항궤양제
JP4710445B2 (ja) 医薬組成物
US4808603A (en) 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and pharmaceutical compositions thereof
CA2196076A1 (en) Acyl imidazopyridines
DE3445356A1 (de) Halogenierte thiophen-verbindungen
KR100661081B1 (ko) 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
KR100609490B1 (ko) 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
GB2050375A (en) 4-Cyanophenyl-1,4- dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
NO309037B1 (no) Substituerte aminoalkylaminopyridiner med virkning ovenfor Helicobacter pylori
KR0154281B1 (ko) 접합고리 피리딘을 함유한 벤즈이미다졸 유도체